ストックスクリーナーアプリを入手
24.69
6.84%
1.58
前日終値:
$23.11
開ける：
$23.48
24時間の取引高:
319.75K
Relative Volume:
1.58
時価総額：
$884.50M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+15.16%
1か月 パフォーマンス:
+7.63%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$23.29
$25.09
1週間の範囲:
$21.53
$25.09
52週間の値動き範囲:
$18.69
$32.75
Ceribell Inc Stock (CBLL) Company Profile
CBLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
24.69 | 884.50M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | 開始されました | BofA Securities | Buy |
| 2024-11-05 | 開始されました | Canaccord Genuity | Buy |
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | 開始されました | William Blair | Outperform |
Ceribell Inc (CBLL) 最新ニュース
CeriBell Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
CeriBell: A Leader In AI-Powered Seizure Detection (NASDAQ:CBLL) - Seeking Alpha
CeriBell (CBLL) to Release Earnings on Tuesday - MarketBeat
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference - GlobeNewswire
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Target Price from Analysts - MarketBeat
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Price Target from Brokerages - Defense World
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewswire
CeriBell, Inc. to Announce Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
CeriBell (CBLL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
CeriBell (CBLL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Nexalin Technology (NASDAQ:NXL) vs. CeriBell (NASDAQ:CBLL) Head-To-Head Contrast - Defense World
CeriBell (NASDAQ:CBLL) Trading 9.1% HigherShould You Buy? - MarketBeat
Beta Bionics targets up to $616 mln valuation in US IPO - Reuters
CeriBell (NASDAQ:CBLL) Receives $32.60 Consensus Price Target from Analysts - Defense World
Brokerages Set CeriBell (NASDAQ:CBLL) Price Target at $32.60 - MarketBeat
Ceribell Expands its Executive Management Team by Two - MPO-mag
CeriBell (NASDAQ:CBLL) Hits New 52-Week LowTime to Sell? - MarketBeat
CeriBell (NASDAQ:CBLL) Shares Down 9.2%Should You Sell? - MarketBeat
CeriBell (NASDAQ:CBLL) Trading Down 3.3%What's Next? - MarketBeat
Contrasting CeriBell (NASDAQ:CBLL) & Cutera (NASDAQ:CUTR) - Defense World
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
CeriBell (NASDAQ:CBLL) Receives $32.60 Consensus PT from Analysts - Defense World
Head to Head Contrast: CeriBell (NASDAQ:CBLL) & Vaso (OTCMKTS:VASO) - Defense World
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs - Marketscreener.com
CeriBell (NASDAQ:CBLL) Shares Down 2.6%Here's Why - MarketBeat
CeriBell (NASDAQ:CBLL) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Ceribell CEO to Present at J.P. Morgan Healthcare Conference 2025: Medical Tech Innovation in Focus - StockTitan
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - The Eastern Progress Online
CeriBell (NASDAQ:CBLL) Price Target Raised to $33.00 at Canaccord Genuity Group - Defense World
CeriBell (NASDAQ:CBLL) Given New $36.00 Price Target at TD Cowen - Defense World
Ceribell shares PT raised by analyst to reflect higher EV/sales momentum - Investing.com UK
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
Top 145+ startups in Smart EEG Devices in Nov, 2024 - Tracxn
CeriBell: Healthcare Technology Stock With A Promising Growth Outlook (NASDAQ:CBLL) - Seeking Alpha
Ceribell appoints Rodenbush as CPO, Price as SVP of Marketing - TipRanks
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing - The Manila Times
Ceribell Strengthens Leadership Team with Key AI Medical Device Executives | CBLL Stock News - StockTitan
Meet the biophysicist whose seizure-detection company is using AI to get a better read on people's brains - Fast Company
FY2024 EPS Estimates for CeriBell Reduced by William Blair - MarketBeat
William Blair Estimates CeriBell's Q1 Earnings (NASDAQ:CBLL) - MarketBeat
Ceribell revenue increases 48% to USD 17.2M in Q3 2024 - Medical Buyer
Ceribell, Inc. Reports Strong Q3 2024 Growth - Yahoo Finance
Ceribell price target raised to $31 from $30 at Canaccord - TipRanks
Ceribell Inc (CBLL) 財務データ
Ceribell Inc (CBLL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Ceribell Inc (CBLL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 10% Owner |
Oct 15 '24 |
Buy |
17.00 |
380,268 |
6,464,556 |
3,967,422 |
| Tammenoms Bakker Juliet | Director |
Oct 15 '24 |
Buy |
17.00 |
237,234 |
4,032,978 |
2,475,110 |
1.16%
0.10%
大文字化:
|
ボリューム (24 時間):